抑郁症患者血清性激素变化及其临床意义
Changes in Serum Sex Hormones in Patients with Depression and Their Clinical Significance
DOI: 10.12677/AP.2023.138413, PDF,   
作者: 徐燕美:云南省检验医学重点实验室,云南 昆明;云南省医学检验临床医学研究中心,云南 昆明;昆明医科大学第一附属医院医学检验科,云南 昆明;蒙自市人民医院检验科,云南 蒙自;段 勇, 李 昕:云南省检验医学重点实验室,云南 昆明;云南省医学检验临床医学研究中心,云南 昆明;昆明医科大学第一附属医院医学检验科,云南 昆明;徐安辉:蒙自市人民医院检验科,云南 蒙自;潘俊希*:云南省检验医学重点实验室,云南 昆明;云南省医学检验临床医学研究中心,云南 昆明;昆明医科大学第一附属医院医学检验科,云南 昆明第一附属医院医学检验科,云南 昆明
关键词: 抑郁性激素HAMD评分HAMA评分Depression Sex Hormone HAMAD Score HAMA Rating
摘要: 目的:探讨抑郁症患者血清性激素水平、卵泡刺激素(follicle stimulating hormone, FSH)/黄体生成素(luteinizing hormone, LH)比值变化,及其与焦虑抑郁症状的相关性。方法:纳入2020年01月至2020年12月在昆明医科大学第一附属医院精神科住院的364例抑郁症患者作为抑郁组,选取同期健康体检人员994例作为对照组,按性别和年龄分为年轻男性抑郁组、老年男性抑郁组、年轻女性抑郁组、围绝经期女性抑郁组、老年女性抑郁组。测定纳入对象血清性激素水平,根据汉密尔顿抑郁量表、汉密尔顿焦虑量表评定病例组抑郁情绪和焦虑症状。采用Mann-Whitney U检验分析抑郁组与对照组血清性激素之间的差异,Pearson相关性分析评估抑郁组性激素与汉密尔顿抑郁量表(HAMD-17)及汉密尔顿焦虑量表(HAMA)评分的相关性。结果:1) 抑郁症患者泌乳素(prolactin, PRL)水平显著高于健康人群(P < 0.05),男性患者中,45岁以上男性患者睾酮(testosterone, T)水平及T/雌二醇(estradiol, E2)高于健康人群(P < 0.05),孕酮(progesterone, P)水平及FSH/LH低于健康人群(P < 0.05);女性患者中,19~45岁女性患者T、FSH、FSH/LH、T/E2比值低于健康人群,E2水平高于健康人群(P < 0.05)。2) 19~45岁女性患者PRL水平与HAMA评分呈正相关(r = 0.195, P < 0.05),FSH/LH与HAMD评分呈正相关(r = 0.264, P < 0.05);45~55岁女性患者PRL水平与HAMA呈负相关(r = −0.251, P < 0.05);55岁以上女性患者FSH/LH与HAMA呈负相关(r = −0.353, P < 0.05),其他性激素指标与HAMD、HAMA评分无相关性(P > 0.05)。结论:不同性别和不同年龄段抑郁症患者血清性激素水平与HAMD、HAMA评分的相关性存在显著差异,性激素指标可作为抑郁症患者的早期诊治参考。
Abstract: Objective: To investigate the changes in serum sex hormone levels and follicle stimulating hormone (FSH)/luteinizing hormone (LH) ratio in patients with depression, and their correlation with anxiety and depressive symptoms. Methods: A total of 364 depressed patients hospitalized in the Department of Psychiatry of the First Affiliated Hospital of Kunming Medical University from January 2020 to December 2020 were included as the depression group, and 994 cases of health examiners during the same period were selected as the control group, and were divided into young male depression group, elderly male depression group, young female depression group, perimenopausal female depression group, and elderly female depression group according to gender and age. The serum sex hormone levels of the included subjects were measured, and the depressed mood and anxiety symptoms of the case group were assessed according to the Hamilton Depression Scale and the Hamilton Anxiety Scale. The Mann-Whitney U test was used to analyze the difference between serum sex hormones in the depressed group and the control group, and the Pearson correlation analysis was used to evaluate the correlation between sex hormones in the depressed group and Hamilton Depression Scale (HAMD-17) and Hamilton Anxiety Scale (HAMA) scores. Results: 1) Prolactin (PRL) levels in depressed patients were significantly higher than those in healthy people (P < 0.05), male patients over 45 years old had testosterone (T) levels and T/estradiol (E2) higher than healthy people (P < 0.05), progesterone (P) levels and FSH/LH were lower than healthy people (P < 0.05); Among female patients, the ratios of T, FSH, FSH/LH, and T/E2 in female patients aged 19~45 years were lower than those in healthy people, and the E2 level was higher than that in healthy people (P < 0.05). 2) The PRL level of female patients aged 19~45 years was positively correlated with the HAMA score (r = 0.195, P < 0.05), and FSH/LH was positively correlated with the HAHD score (r = 0.264, P < 0.05). The PRL level of female patients aged 45~55 years was negatively correlated with HAMA (r = −0.251, P < 0.05). FSH/LH was negatively correlated with HAMA in women over 55 years of age (r = −0.353, P < 0.05), and other sex hormone indexes were not correlated with HAMD and HAMA scores (P > 0.05). Conclusion: The correlation between serum sex hormone levels and HAMD and HAMA scores in depressed patients of different genders and different age groups is significantly different. Sex hormone indexes can be used as a reference for early diagnosis and treatment of depressed patients.
文章引用:徐燕美, 段勇, 李昕, 徐安辉, 潘俊希 (2023). 抑郁症患者血清性激素变化及其临床意义. 心理学进展, 13(8), 3293-3301. https://doi.org/10.12677/AP.2023.138413

参考文献

[1] 蔡菁, 凌冬(2020). 帕罗西汀联合运动行为干预治疗抑郁症疗效及对γ-氨基丁酸的影响. 国际检验医学杂志, 41(20), 2485-2488.
[2] 陈美惠, 贾佳, 曹燕丽, 龚光明(2021). 抑郁症患者性激素异常及治疗的研究进展. 东南国防医药, 23(6), 633-636.
[3] 陈雪春, 陈景洲(2022). 产后抑郁与分娩前后血清Hcy、E2、5-HT、催乳素水平的相关性. 中国妇幼健康研究, 33(6), 20-24.
[4] 雷荣(2020). 抑郁障碍患者雌激素水平的临床意义探讨. 硕士学位论文, 唐山: 华北理工大学.
[5] 李剑, 高勤, 程伟, 栗伟(2022). 芍药甘草汤加减联合氯氮平治疗抗精神病药物所致高催乳素血症的疗效及对性激素的影响. 四川中医, 40(8), 120-123.
[6] 李玲, 谢华, 戴剑峰(2014). 下丘脑-垂体-性腺轴与抑郁症相关性的研究进展. 医学综述, 20(21), 3872-3874.
[7] 刘亚丽, 孟庆丰(2016). 女性脑卒中后抑郁症患者血清性激素变化及价值评价. 中国药物经济学, 11(8), 90-92.
[8] 马曙铮, 孟宝丽, 王宏锋(2020). 产后抑郁症患者HPA轴激素、甲状腺功能及性激素的水平分析. 国际精神病学杂志, 47(3), 504-506+513.
[9] 王海青, 张达明, 白云, 宋志娇(2022). 围绝经期抑郁女性5-羟色胺转运体启动子区域基因多态性及与性激素水平的相关性. 中国妇幼保健, 37(9), 1551-1554.
[10] 王瑞强(2022). 动机访谈干预联合帕罗西汀片治疗产后抑郁的效果. 中国妇幼保健, 37(10), 1760-1762.
[11] 邬朝晖, 晏洁梅, 陈桂丹, 梁新国(2022). 围绝经期女性睡眠质量、情绪障碍及性激素水平与认知功能相关性分析. 中国医学工程, 30(7), 65-68.
[12] 中国神经科学学会精神病学基础与临床分会精神分裂症临床研究联盟(2021). 抗精神病药所致高泌乳素血症干预对策的专家共识. 中华精神科杂志, 54(3), 163-169.
[13] Borgsted, C., Høgh, S., Høgsted, E. S., Fonnesbech-Sandberg, L., Ekelund, K., Albrechtsen, C. K. et al. (2022). The Role of Central Serotonergic Markers and Estradiol Changes in Perinatal Mental Health. Acta Psychiatrica Scandinavica, 146, 357-369.[CrossRef] [PubMed]
[14] Bukstein, O. G. (2022). Screening for Adolescent Depression and Suicide Risk. JAMA, 328, 1504-1505.[CrossRef] [PubMed]
[15] Chen, Z., Shen, X., Tian, K., Liu, Y., Xiong, S., Yu, Q. et al. (2020). Bioavailable Testosterone Is Associated with Symptoms of Depression in Adult Men. Journal of International Medical Research, 48.[CrossRef] [PubMed]
[16] de Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C., & Pierroz, D. D. (2016). Revised Global Consensus Statement on Menopausal Hormone Therapy. Maturitas, 91, 153-155.[CrossRef] [PubMed]
[17] Delgado-Alvarado, M., Tordesillas-Gutierrez, D., Ayesa-Arriola, R., Canal, M., Ortiz-García de la Foz, V., Labad, J., & Crespo-Facorro, B. (2019). Plasma Prolactin Levels Are Associated with the Severity of Illness in Drug-Naive First-Episode Psychosis Female Patients. Archives of Women’s Mental Health, 22, 367-373.[CrossRef] [PubMed]
[18] Eck, S. R., & Bangasser, D. A. (2020). The Effects of Early Life Stress on Motivated Behaviors: A Role for Gonadal Hormones. Neuroscience & Biobehavioral Reviews, 119, 86-100.[CrossRef] [PubMed]
[19] Elgellaie, A., Larkin, T., Kaelle, J., Mills, J., & Thomas, S. (2021). Plasma Prolactin Is Higher in Major Depressive Disorder and Females, Associated with Anxiety, Hostility, Somatization, Psychotic Symptoms and Heart Rate. Comprehensive Psychoneuroendocrinology, 6, Article ID: 100049.[CrossRef] [PubMed]
[20] Kundakovic, M., & Rocks, D. (2022). Sex Hormone Fluctuation and Increased Female Risk for Depression and Anxiety Disorders: From Clinical Evidence to Molecular Mechanisms. Frontiers in Neuroendocrinology, 66, Article ID: 101010.[CrossRef] [PubMed]
[21] Margolese, H. C. (2000). The Male Menopause and Mood: Testosterone Decline and Depression in the Aging Male—Is There a Link? Journal of Geriatric Psychiatry and Neurology, 13, 93-101.[CrossRef] [PubMed]
[22] McHenry, J., Carrier, N., Hull, E., & Kabbaj, M. (2014). Sex Differences in Anxiety and Depression: Role of Testosterone. Frontiers in Neuroendocrinology, 35, 42-57.[CrossRef] [PubMed]
[23] Smith, K. (2014). Mental Health: A World of Depression. Nature, 515, 181.[CrossRef] [PubMed]
[24] Torner, L. (2016). Actions of Prolactin in the Brain: From Physiological Adaptations to Stress and Neurogenesis to Psychopathology. Frontiers in Endocrinology (Lausanne), 7, Article No. 25.[CrossRef] [PubMed]